In addition, a proportional decrease in enzymatic antioxidants (catalase) was noticed in tumor lysates from groups treated with LCL-SIM (P < 0.05), LCL-DMXAA (P < 0.01) and the liposomal combination therapy (Fig. 5B, P < 0.05). The gene discussed is CAT; the disease is neoplasm.